Skip to main content
Aqua Bio Technology logo

Aqua Bio Technology — Investor Relations & Filings

Ticker · ABT ISIN · NO0010307135 LEI · 529900RG33DF0N88RJ88 Euronext Expand Manufacturing
Open in API
Filings indexed 1,258 across all filing types
Latest filing 2026-05-27 Proxy Solicitation & In…
Country NO Norway
Listing Euronext Expand ABT

About Aqua Bio Technology

https://aquabiotechnology.com/

Aqua Bio Technology (ABT) is a biotechnology company that develops, manufactures, and commercializes natural and sustainable active ingredients for the international cosmetics and skincare industry. The company leverages science and technology to discover ingredients from natural sources, including plants, algae, and marine life. Its portfolio is centered on providing sustainable alternatives to petroleum-based substances. A key proprietary ingredient is Aquabeautine XL™, which is derived from proteins found in the hatching fluid of salmon, demonstrating a focus on upcycling biological byproducts into high-value cosmetic components. ABT's products cater to the increasing demand for effective and environmentally conscious skincare solutions.

Recent filings

Filing Released Lang Actions
Aqua Bio Technology ASA: Innkalling til ordinær generalforsamling - Attachment: Aqua Bio Technology ASA Innkalling Til Ordinær Generalforsamling 2026.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal “Innkalling til ordinær generalforsamling” (notice of annual general meeting) for Aqua Bio Technology ASA, including the meeting agenda, proposed resolutions, and proxy forms for shareholders. It is sent to solicit votes and provide information to shareholders ahead of the AGM. This corresponds to the Proxy Solicitation & Information Statement category (PSI).
2026-05-27 Norwegian Bokmål
Aqua Bio Technology ASA: Innkalling til ordinær generalforsamling - Attachment: Aqua Bio Technology ASA- Innkalling til ordinær generalforsamling.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a press release (“Pressemelding”) from Aqua Bio Technology ASA announcing and attaching the notice (innkalling) for the ordinary general meeting of shareholders on June 17, 2026. It is a convocation sent to shareholders to provide information and request participation/votes. This falls squarely under Proxy Solicitation & Information Statement (PSI).
2026-05-27 Norwegian Nynorsk
Aqua Bio Technology ASA: Innkalling til ordinær generalforsamling
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a notice (“innkalling”) convening the ordinary general meeting, providing shareholders with meeting details and requesting participation. This type of communication is best classified as a Proxy Solicitation & Information Statement (PSI), as it notifies shareholders and provides information for voting and meeting attendance.
2026-05-27 Norwegian Nynorsk
Finansiell kalender
Report Publication Announcement Classification · 85% confidence The document is a brief financial calendar notice listing future reporting and AGM dates for Aqua Bio Technology ASA. It does not contain actual financial data or the report itself but announces the timing of upcoming reports, fitting the definition of a Report Publication Announcement rather than an interim report or any other category. Hence, it should be classified as RPA.
2026-05-27 Norwegian Bokmål
Finansiell kalender
Report Publication Announcement Classification · 93% confidence The document is a financial calendar listing upcoming dates for the annual report (Årsrapport), half‐year report (Halvårsrapport), and the ordinary general meeting. It does not contain the reports themselves, but announces the timing of their publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-27 Norwegian
Aqua Bio Technology ASA: Godkjent prospekt - Attachment: 260421 Aqua Bio Technology ASA Prospectus.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a full listing prospectus for 12,000,000 new shares issued in connection with a private placement and debt conversion, prepared under the EU Prospectus Regulation for admission to trading on Euronext Expand. It is not an annual or interim financial report, earnings release, or management announcement, but a detailed share issuance document. The most fitting category in our taxonomy is ‘Share Issue/Capital Change’ (SHA).
2026-04-21 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.